Pre-treatment technologies for dark fermentative hydrogen production : Current advances and future directions

Copyright © 2017 Elsevier Ltd. All rights reserved.

Bibliographische Detailangaben
Veröffentlicht in:Waste management (New York, N.Y.). - 1999. - 71(2018) vom: 30. Jan., Seite 734-748
1. Verfasser: Rafieenia, Razieh (VerfasserIn)
Weitere Verfasser: Lavagnolo, Maria Cristina, Pivato, Alberto
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2018
Zugriff auf das übergeordnete Werk:Waste management (New York, N.Y.)
Schlagworte:Journal Article Dark fermentation Hydrogen Inoculum pre-treatment Substrate pre-treatment Carbon 7440-44-0 7YNJ3PO35Z
Beschreibung
Zusammenfassung:Copyright © 2017 Elsevier Ltd. All rights reserved.
Hydrogen is regarded as a clean and non-carbon fuel and it has a higher energy content compared to carbon fuels. Dark fermentative hydrogen production from organic wastes is the most promising technology for commercialization among chemical and biological methods. Using mixed microflora is favored in terms of easier process control and substrate conversion efficiencies instead of pure cultures. However, mixed cultures should be first pre-treated in order to select sporulating hydrogen producing bacteria and suppress non-spore forming hydrogen consumers. Various inoculum pre-treatments have been used to enhance hydrogen production by dark fermentation including heat shock, acid or alkaline treatment, chemical inhibition, aeration, irradiation and inhibition by long chain fatty acids. Regarding substrate pre-treatment, that is performed with the aim of enhanced substrate biodegradability, thermal pre-treatment, pH adjustment using acid or base, microwave irradiation, sonication and biological treatment are the most commonly studied technologies. This article reviews the most investigated pre-treatment technologies applied for either inoculum or substrate prior to dark fermentation, the long-term effects of varying pre-treatment methods and the subsequently feasibility of each method for commercialization
Beschreibung:Date Completed 13.08.2018
Date Revised 02.12.2018
published: Print-Electronic
Citation Status MEDLINE
ISSN:1879-2456
DOI:10.1016/j.wasman.2017.05.024